Lori M. Newman

FDA investigator

Appears on 18 documents from 2021 to 2026, most often at sites in Massachusetts. Most often cites production record review (21 CFR 211.192).

18
Documents on file
7.5
Observations per 483
2021
First seen
2026
Most recent

What they cite most

From 130 observations

Activity by year

2021: 2, 2022: 2, 2023: 4, 2024: 5, 2025: 4, 2026: 1

Where

Massachusetts 3 · New Hampshire 3 · India 2 · New York 2 · Rhode Island 2 · Connecticut 1

Is Lori M. Newman coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

18 documents, newest first
FirmOpen
483 Lantheus Medical Imaging, Inc.Apr 9, 2026
483 Fresenius Kabi Compounding, LLCNov 6, 2025 · Canton, Massachusetts
483 Fresenius Kabi Compounding, LLCNov 5, 2025 · Canton, Massachusetts
483 NTP RADIOISOTOPESApr 11, 2025 · BRITS, South Africa
483 SpecGx LLCJan 17, 2025 · Hobart, New York
483 Denison Pharmaceuticals, LLCJul 29, 2024 · Lincoln, Rhode Island
483 Tom's of Maine, Inc.May 22, 2024 · Sanford, Maine

About this profile

What does Lori M. Newman inspect?

Lori M. Newman appears on 18 documents on file covering 16 sites, most often in Massachusetts.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.42(a) and 21 CFR 211.113.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Lori M. Newman is dated Apr 9, 2026.